Ellis Andrea, a director at BridgeBio Pharma ($BBIO), sold shares on the open market four times in the last year, totaling $6.4 million. Her most recent sale occurred on March 4, 2026. These sales rank her 1607th among over 11,600 insiders by value sold, below the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Director | M | Stock Option (right to buy) | 64921 | $0.00 | 0.0000 | 192,708,813 | 100.00% | 0.03% |
| March 4, 2026 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Director | S | Common Stock | 64921 | $64.87 | 18,589.0000 | 192,708,813 | 77.74% | 0.03% |
| March 4, 2026 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Director | M | Common Stock | 64921 | $8.45 | 83,510.0000 | 192,708,813 | 349.24% | 0.03% |
| Aug. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | M | Common Stock | 17167 | $16.75 | 35,756.0000 | 190,188,626 | 92.35% | 0.01% |
| Aug. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | S | Common Stock | 17167 | $49.00 | 18,589.0000 | 190,188,626 | 48.01% | 0.01% |
| Aug. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | M | Stock Option (right to buy) | 17167 | $0.00 | 34,334.0000 | 190,188,626 | 33.33% | 0.01% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | A | Common Stock | 6589 | $0.00 | 18,589.0000 | 190,188,626 | 54.91% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| April 14, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | S | Common Stock | 10000 | $35.00 | 12,000.0000 | 190,188,626 | 45.45% | 0.01% |
| April 14, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | M | Stock Option (right to buy) | 10000 | $0.00 | 64,921.0000 | 190,188,626 | 13.35% | 0.01% |
| April 14, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | M | Common Stock | 10000 | $8.45 | 22,000.0000 | 190,188,626 | 83.33% | 0.01% |
| April 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | M | Common Stock | 30000 | $8.45 | 42,000.0000 | 190,188,626 | 250.00% | 0.02% |
| April 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | S | Common Stock | 30000 | $34.05 | 12,000.0000 | 190,188,626 | 71.43% | 0.02% |
| April 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | M | Stock Option (right to buy) | 30000 | $0.00 | 74,921.0000 | 190,188,626 | 28.59% | 0.02% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | Ellis Andrea | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |